International Stem Cell Corporation Completes Clinical Testing of a New Compound – CNNMoney
International Stem Cell Corporation Completes Clinical Testing of a New CompoundCNNMoneyInternational Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, anno… Continue reading
